HETEROCYCLIC COMPOUND

Provided is a prophylactic or therapeutic agent for autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus), which has an excellent Tyk2 inhibition activity. The present...

Full description

Saved in:
Bibliographic Details
Main Authors YOSHIDA, MASATO, KUSUMOTO, TOMOKAZU, KIM, KWANG OK, LEE, GIL NAM, YOON, CHEOLHWAN, KANG, HYUN BIN, YOGO, TAKATOSHI, JEON, HYE SUN, MARUI, SHOGO, SETO, MASAKI, SUZUKI, HIDEO, ODA, TSUNEO, ISHICHI, YUJI, NAGAMIYA, HIROYUKI, RHIM, CHUL YUN
Format Patent
LanguageEnglish
French
Japanese
Published 29.08.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Provided is a prophylactic or therapeutic agent for autoimmune diseases (e.g., psoriasis, rheumatoid arthritis, inflammatory bowel disease, Sjogren's syndrome, Behcet's disease, multiple sclerosis, systemic lupus erythematosus), which has an excellent Tyk2 inhibition activity. The present invention relates to a compound represented by formula (I) [wherein each symbol is as defined in the description attached] or a salt thereof. L'invention concerne un agent prophylactique ou thérapeutique destiné à des maladies auto-immunes (par exemple le psoriasis, l'arthrite rhumatoïde, la maladie inflammatoire de l'intestin, le syndrome de Sjogren, la maladie de Behcet, la sclérose en plaques, le lupus érythémateux systémique), qui présente une excellente activité d'inhibition de Tyk2. La présente invention concerne un composé représenté à la formule (I) [dans laquelle chaque symbole est tel que défini dans la description ci-jointe] ou un sel de celui-ci.
Bibliography:Application Number: WO2013JP54054